Literature DB >> 16728443

Of mice and men; the translational physiology of a genetic form of lymphoedema.

P S Mortimer1, J R Levick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16728443      PMCID： PMC1817771          DOI： 10.1113/jphysiol.2006.114124

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  6 in total

Review 1.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 2.  Milroy disease and the VEGFR-3 mutation phenotype.

Authors:  G Brice; A H Child; A Evans; R Bell; S Mansour; K Burnand; M Sarfarazi; S Jeffery; P Mortimer
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

Review 3.  Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.

Authors:  David G Jackson
Journal:  APMIS       Date:  2004 Jul-Aug       Impact factor: 3.205

4.  Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema.

Authors:  Tine V Karlsen; Marika J Karkkainen; Kari Alitalo; Helge Wiig
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

5.  Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

Authors:  A Kaipainen; J Korhonen; T Mustonen; V W van Hinsbergh; G H Fang; D Dumont; M Breitman; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

6.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Authors:  V Joukov; K Pajusola; A Kaipainen; D Chilov; I Lahtinen; E Kukk; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.